Skip to main content

Articles

Original Research
Burden of Disease: The Psychosocial Impact of Rosacea on a Patient’s Quality of Life
Stakeholder Perspective
The Psychosocial Impact of Skin Disorders: Time for a Closer Look?
Read More
ASCO President Highlights Bridges to Conquer Cancer
Read More
Off-Label Drug Use in Oncology Accounts for 18% of Spending
Read More
Melanoma, Oncology
Immunotherapies Take Center Stage in Melanoma
Read More
Cancer Drug Pipeline Is Bustling
Read More
FDA Approvals
Mekinist and Dabrafenib Approved for Advanced Melanoma with BRAF Mutations
Read More
FDA Approvals
Lenalidomide Receives New Indication for Mantle-Cell Lymphoma
Read More
Dermatology, Original Research
Burden of Disease: The Psychosocial Impact of Rosacea on a Patient’s Quality of Life
Stakeholder Perspective
The Psychosocial Impact of Skin Disorders: Time for a Closer Look?
Read More
FDA Approvals
Simbrinza (Brinzolamide/Brimonidine Tartrate) Receives FDA Approval for the Treatment of Open-Angle Glaucoma or Ocular Hypertension
Read More
FDA Approvals
Ilaris (Canakinumab) Receives a New Indication for the Treatment of Systemic Juvenile Idiopathic Arthritis
Read More
Page 175 of 244
Results 1741 - 1750 of 2434